Skip to content

Clinical trials

Phase 2 Scleroderma, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Phase 2 Clear all

103 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20041
20051
20063
20074
20083
20094
20102
20115
20122
20133
20143
20155
20164
20175
20182
20197
20206
20218
20224
20232
20245
20256
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Terminated17
Recruiting16
Unknown status8
Not yet recruiting7
Active, not recruiting4
Suspended2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris4
Hospital for Special Surgery, New York4
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's3
Amgen2
Assistance Publique Hopitaux De Marseille2
Charite University, Berlin, Germany2
Fred Hutchinson Cancer Center2
Heidelberg University2
ISDIN2
Lakefront Biotherapeutics NV2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic103
Scleroderma, Diffuse32
Lung Diseases, Interstitial14
Raynaud Disease9
Connective Tissue Diseases7
Skin Diseases7
Hypertension, Pulmonary5
Autoimmune Diseases4
Lupus Erythematosus, Systemic4
Scleroderma, Limited4

Trials

Showing 1 to 25 of 103. Each trial links to its page on Pharma Observatory.

3 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.